Cargando…
COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study
BACKGROUND: Individuals with autistic spectrum disorder (ASD) are more susceptible to COVID-19 morbidity and should therefore be prioritized for vaccination. Although individuals with neurodevelopmental disabilities are given some priority in Israel, it is unclear to what extent individuals with ASD...
Autores principales: | Weinstein, Orly, Krieger, Israel, Cohen, Arnon Dov, Tzur Bitan, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445801/ https://www.ncbi.nlm.nih.gov/pubmed/34548878 http://dx.doi.org/10.1016/j.rasd.2021.101865 |
Ejemplares similares
-
COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
por: Krieger, Israel, et al.
Publicado: (2021) -
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study
por: Tzur Bitan, Dana, et al.
Publicado: (2021) -
Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
por: Tzur Bitan1,2, Dana, et al.
Publicado: (2022) -
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study
por: Tzur Bitan, Dana, et al.
Publicado: (2021) -
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study
por: Kridin, Khalaf, et al.
Publicado: (2022)